Conjugated linoleic acid protects against age-associated bone loss in C57BL/6 female mice

Journal of Nutritional Biochemistry

Volumn 18, Issue 7, 2007, Pages 467-474

  Rahman, Md Mizanur ^a   Bhattacharya, Arunabh ^a   Banu, Jameela ^a   Fernandes, Gabriel ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Aging; Bone; Conjugated linoleic acid; Cytokines; Inflammation

Indexed keywords

ALPHA TOCOPHEROL; CASEIN; CELLULOSE; CONJUGATED LINOLEIC ACID; CORN OIL; CYSTEINE; CYTOKINE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; STARCH; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANIMAL EXPERIMENT; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; CALCIUM METABOLISM; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIFESTYLE; MOUSE; MUSCLE MASS; NONHUMAN; NUTRITIONAL ASSESSMENT; OSTEOLYSIS; OSTEOPOROSIS; PROPHYLAXIS; PROTEIN BLOOD LEVEL; WEIGHT GAIN;

ADIPOSE TISSUE; AGING; ANIMALS; BODY WEIGHT; FEMALE; LINOLEIC ACIDS, CONJUGATED; MICE; MICE, INBRED C57BL; OSTEOPOROSIS;

MUS; ZEA MAYS;

EID: 34249910611     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.08.002     Document Type: Article

References (77)

1. May H., Murphy S., and Khaw K.T. Age-associated bone loss in men and women and its relationship to weight. Age Ageing 23 (1994) 235-240
2. McGarry KA, Kiel DP. Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture. Postgrad Med 2000;108:79-82, 85-8, 91.
3. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341 (1993) 72-75
4. Chevalley T., Rizzoli R., Nydegger V., et al. Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur. Osteoporos Int 1 (1991) 147-154
5. Tucker K.L., Chen H., Hannan M.T., et al. Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 76 (2002) 245-252
6. Bhattacharya A., Rahman M., Banu J., et al. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by n-3 fatty acids. J Am Coll Nutr 24 (2005) 200-209
7. Sun D., Krishnan A., Zaman K., Lawrence R., Bhattacharya A., and Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18 (2003) 1206-1216
8. Banu J., Bhattacharya A., Rahman M., O'Shea M., and Fernandes G. Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice. Lipids Health Dis 5 (2006) 7
9. Bhattacharya A., Banu J., Rahman M., Causey J., and Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem (2006)
10. House R.L., Cassady J.P., Eisen E.J., McIntosh M.K., and Odle J. Conjugated linoleic acid evokes de-lipidation through the regulation of genes controlling lipid metabolism in adipose and liver tissue. Obes Rev 6 (2005) 247-258
11. Chung S., Brown J.M., Sandberg M.B., and McIntosh M. Trans-10,cis-12 CLA increases adipocyte lipolysis and alters lipid droplet-associated proteins: role of mTOR and ERK signaling. J Lipid Res 46 (2005) 885-895
12. Larsen T.M., Toubro S., and Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 44 (2003) 2234-2241
13. Durgam V.R., and Fernandes G. The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen response system. Cancer Lett 116 (1997) 121-130
14. Belury M.A. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 22 (2002) 505-531
15. Wahle K.W., Heys S.D., and Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res 43 (2004) 553-587
16. Chung S., Brown J.M., Provo J.N., Hopkins R., and McIntosh M.K. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem 280 (2005) 38445-38456
17. Brownbill R.A., Petrosian M., and Ilich J.Z. Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. J Am Coll Nutr 24 (2005) 177-181
18. Park Y., Albright K.J., Liu W., Storkson J.M., Cook M.E., and Pariza M.W. Effect of conjugated linoleic acid on body composition in mice. Lipids 32 (1997) 853-858
19. Watkins B.A., Lippman H.E., Le Bouteiller L., Li Y., and Seifert M.F. Bioactive fatty acids: role in bone biology and bone cell function. Prog Lipid Res 40 (2001) 125-148
20. 2 production, insulin-like growth factor-I concentration and formation rate in chicks. J Nutr 127 (1997) 1084-1091
21. Thiel-Cooper R.L., Parrish Jr. F.C., Sparks J.C., Wiegand B.R., and Ewan R.C. Conjugated linoleic acid changes swine performance and carcass composition. J Anim Sci 79 (2001) 1821-1828
22. Li Y., Seifert M.F., Ney D.M., et al. Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 14 (1999) 1153-1162
23. Kelly G.S. Conjugated linoleic acid: a review. Altern Med Rev 6 (2001) 367-382
24. Demaree S.R., Gilbert C.D., Mersmann H.J., and Smith S.B. Conjugated linoleic acid differentially modifies fatty acid composition in subcellular fractions of muscle and adipose tissue but not adiposity of postweaning pigs. J Nutr 132 (2002) 3272-3279
25. Bhattacharya A., Rahman M.M., Sun D., et al. The combination of dietary conjugated linoleic acid and treadmill exercise lowers gain in body fat mass and enhances lean body mass in high fat-fed male Balb/C mice. J Nutr 135 (2005) 1124-1130
26. Nagy T.R., and Clair A.L. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 8 (2000) 392-398
27. Wu J., Wang X., Chiba H., et al. Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism 53 (2004) 942-948
28. Bhattacharya A., Sun D., Rahman M., and Fernandes G. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice. J Nutr Biochem (2006)
29. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 (2000) 1504-1508
30. Geusens P.P., Landewe R.B., Garnero P., et al. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 54 (2006) 1772-1777
31. Halleen J.M., Alatalo S.L., Suominen H., Cheng S., Janckila A.J., and Vaananen H.K. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 15 (2000) 1337-1345
32. Nenonen A., Cheng S., Ivaska K.K., et al. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J Bone Miner Res 20 (2005) 1804-1812
33. Rosen C.J. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 353 (2005) 595-603
34. Lacey Jr. J.V., Mink P.J., Lubin J.H., et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288 (2002) 334-341
35. Kruger M.C., and Horrobin D.F. Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res 36 (1997) 131-151
36. Claassen N., Coetzer H., Steinmann C.M., and Kruger M.C. The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats. Prostaglandins Leukot Essent Fatty Acids 53 (1995) 13-19
37. Watkins B.A., and Seifert M.F. Conjugated linoleic acid and bone biology. J Am Coll Nutr 19 (2000) 478S-486S
38. Kelly O., Cusack S., Jewell C., and Cashman K.D. The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats. Br J Nutr 90 (2003) 743-750
39. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51 (2000) 245-270
40. Bruunsgaard H., Pedersen M., and Pedersen B.K. Aging and proinflammatory cytokines. Curr Opin Hematol 8 (2001) 131-136
41. Ferrucci L., Corsi A., Lauretani F., et al. The origins of age-related proinflammatory state. Blood 105 (2005) 2294-2299
42. Morley J.E., and Baumgartner R.N. Cytokine-related aging process. J Gerontol A Biol Sci Med Sci 59 (2004) M924-M929
43. Fujita T., Matsui T., Nakao Y., Shiozawa S., and Imai Y. Cytokines and osteoporosis. Ann N Y Acad Sci 587 (1990) 371-375
44. Goldring S.R. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 42 Suppl 2 (2003) ii11-ii16
45. Jilka R.L., Hangoc G., Girasole G., et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257 (1992) 88-91
46. Manolagas S.C. Role of cytokines in bone resorption. Bone 17 (1995) S63-S67
47. Manolagas S.C., and Jilka R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332 (1995) 305-311
48. Troen B.R. Molecular mechanisms underlying osteoclast formation and activation. Exp Gerontol 38 (2003) 605-614
49. 2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172 (2004) 2504-2510
50. Raisz L.G. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 125 (1995) 2024S-2027S
51. Okada Y., Lorenzo J.A., Freeman A.M., et al. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 105 (2000) 823-832
52. Poli V., Balena R., Fattori E., et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13 (1994) 1189-1196
53. Cappellen D., Luong-Nguyen N.H., Bongiovanni S., Grenet O., Wanke C., and Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NB Fkappa. J Biol Chem 277 (2002) 21971-21982
54. Kimble R.B., Srivastava S., Ross F.P., Matayoshi A., and Pacifici R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 271 (1996) 28890-28897
55. Hofbauer L.C., Lacey D.L., Dunstan C.R., Spelsberg T.C., Riggs B.L., and Khosla S. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25 (1999) 255-259
56. Rahman M.M., Kukita A., Kukita T., Shobuike T., Nakamura T., and Kohashi O. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101 (2003) 3451-3459
57. Cheng W.L., Lii C.K., Chen H.W., Lin T.H., and Liu K.L. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway. J Agric Food Chem 52 (2004) 71-78
58. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., and Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3 (1997) 1285-1289
59. Lamp E.C., and Drexler H.G. Biology of tartrate-resistant acid phosphatase. Leuk Lymphoma 39 (2000) 477-484
60. Igarashi Y., Lee M.Y., and Matsuzaki S. Acid phosphatases as markers of bone metabolism. J Chromatogr B Analyt Technol Biomed Life Sci 781 (2002) 345-358
61. Richelson L.S., Wahner H.W., Melton III L.J., and Riggs B.L. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 311 (1984) 1273-1275
62. Orwoll E.S., Bauer D.C., Vogt T.M., and Fox K.M. Axial bone mass in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 124 (1996) 187-196
63. Crepaldi G., and Maggi S. Sarcopenia and osteoporosis: a hazardous duet. J Endocrinol Invest 28 (2005) 66-68
64. Nguyen T.V., Howard G.M., Kelly P.J., and Eisman J.A. Bone mass, lean mass, and fat mass: same genes or same environments?. Am J Epidemiol 147 (1998) 3-16
65. Fiatarone M.A., O'Neill E.F., Ryan N.D., et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330 (1994) 1769-1775
66. Castaneda C., Charnley J.M., Evans W.J., and Crim M.C. Elderly women accommodate to a low-protein diet with losses of body cell mass, muscle function, and immune response. Am J Clin Nutr 62 (1995) 30-39
67. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
68. Kralisch S., Klein J., Lossner U., et al. Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes. FEBS Lett 579 (2005) 6417-6422
69. Spate U., and Schulze P.C. Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care 7 (2004) 265-269
70. Ohashi A., Matsushita Y., Kimura K., Miyashita K., and Saito M. Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decreased production of adiponectin and leptin. J Nutr Sci Vitaminol (Tokyo) 50 (2004) 416-421
71. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49 (2000) 1534-1542
72. Riserus U., Vessby B., Arner P., and Zethelius B. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47 (2004) 1016-1019
73. Clement L., Poirier H., Niot I., et al. Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43 (2002) 1400-1409
74. Tsuboyama-Kasaoka N., Miyazaki H., Kasaoka S., and Ezaki O. Increasing the amount of fat in a conjugated linoleic acid-supplemented diet reduces lipodystrophy in mice. J Nutr 133 (2003) 1793-1799
75. Wargent E., Sennitt M.V., Stocker C., et al. Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation. Lipids Health Dis 4 (2005) 3
76. Vendrell J., Broch M., Vilarrasa N., et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12 (2004) 962-971
77. Javadi M., Beynen A.C., Hovenier R., et al. Prolonged feeding of mice with conjugated linoleic acid increases hepatic fatty acid synthesis relative to oxidation. J Nutr Biochem 15 (2004) 680-687